A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.

NCT00996567 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

DRUG: Cetuximab (Erbitux)

Sponsor

University Hospital, Ghent

Collaborators

[object Object]